Intra-Cellular Therapies Stock (NASDAQ: ITCI)

Intra-Cellular Therapies

INTRA-CELLULAR THERAPIES INC

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. It maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

jnj johnson shutter

Biotech

News

Health Care

General

ITCI

NMRA

Johnson &amp; Johnson discontinues aticaprant&#39;s Phase 3 trial but explores future options. Another depression drug Spravato sales hit $1.01 billion

Johnson &amp; Johnson Stops Late-Stage Depression Study Over &#39;Insufficient Efficacy&#39;

nike shutter2

Price Target

Markets

Analyst Ratings

Trading Ideas

NICE

RIVN

Nike To Rally Over 50%? Here Are 10 Top Analyst Forecasts For Monday

Indianapolis,-,Circa,July,2019:,Conagra,Brands,Manufacturing,Plant.,Conagra

Downgrades

EXEL

This Conagra Brands Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Intra-Cellular Therapies Inc. - Common Stock

Intra-Cellular Therapies Inc

Legal

Press Releases

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, ITCI, EDBL on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN and ITCI on Behalf of Shareholders

Small Cap

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LTRPA, OMIC, ITCI, CCNE on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, ITCI, HEES, SSTK on Behalf of Shareholders

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK and ITCI on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LGTY, ENFN, ITCI, SSTK on Behalf of Shareholders

Earnings

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results

ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc. Is Fair to Shareholders

INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITCI, PWOD, EBTC on Behalf of Shareholders

CCNE

EBTC

EDBL

ENFN

HEES

LGTY

LTRPA

LTRPB

OMIC

PWOD

SSTK

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

HUTCHMED (China) Limited - American Depositary Shares

HUTCHMED (China)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Organon

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pfizer

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Comments

Intra-Cellular Therapies

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga